VIEMED HEALTHCARE INC (VMD) Stock Fundamental Analysis
NASDAQ:VMD - CA92663R1055 - Common Stock
7.19 USD
-0.18 (-2.44%)
Overall VMD gets a fundamental rating of 6 out of 10. We evaluated VMD against 102 industry peers in the Health Care Providers & Services industry. While VMD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. VMD is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, VMD could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
VMD had positive earnings in the past year.
VMD had a positive operating cash flow in the past year.
VMD had positive earnings in each of the past 5 years.
In the past 5 years VMD always reported a positive cash flow from operatings.
1.2 Ratios
VMD has a better Return On Assets (7.57%) than 90.20% of its industry peers.
Looking at the Return On Equity, with a value of 10.00%, VMD is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
VMD has a better Return On Invested Capital (7.91%) than 74.51% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VMD is in line with the industry average of 9.04%.
The last Return On Invested Capital (7.91%) for VMD is above the 3 year average (7.66%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.57% | ||
| ROE | 10% | ||
| ROIC | 7.91% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
1.3 Margins
VMD has a better Profit Margin (5.80%) than 82.35% of its industry peers.
In the last couple of years the Profit Margin of VMD has declined.
VMD's Operating Margin of 6.82% is fine compared to the rest of the industry. VMD outperforms 68.63% of its industry peers.
VMD's Operating Margin has declined in the last couple of years.
VMD has a Gross Margin of 58.33%. This is amongst the best in the industry. VMD outperforms 80.39% of its industry peers.
VMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.82% | ||
| PM (TTM) | 5.8% | ||
| GM | 58.33% |
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
2. Health
2.1 Basic Checks
VMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, VMD has more shares outstanding
Compared to 5 years ago, VMD has more shares outstanding
Compared to 1 year ago, VMD has an improved debt to assets ratio.
2.2 Solvency
VMD has an Altman-Z score of 6.25. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of VMD (6.25) is better than 87.25% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that VMD is not too dependend on debt financing.
The Debt to Equity ratio of VMD (0.02) is better than 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.25 |
ROIC/WACC0.89
WACC8.93%
2.3 Liquidity
A Current Ratio of 1.48 indicates that VMD should not have too much problems paying its short term obligations.
VMD has a Current ratio (1.48) which is in line with its industry peers.
VMD has a Quick Ratio of 1.37. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
VMD has a Quick ratio of 1.37. This is comparable to the rest of the industry: VMD outperforms 50.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 41.67% over the past year.
Measured over the past 5 years, VMD shows a small growth in Earnings Per Share. The EPS has been growing by 4.01% on average per year.
The Revenue has grown by 17.11% in the past year. This is quite good.
Measured over the past years, VMD shows a very strong growth in Revenue. The Revenue has been growing by 22.80% on average per year.
EPS 1Y (TTM)41.67%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%100%
Revenue 1Y (TTM)17.11%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%14.72%
3.2 Future
VMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.89% yearly.
Based on estimates for the next years, VMD will show a quite strong growth in Revenue. The Revenue will grow by 17.73% on average per year.
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 21.15, VMD is valued on the expensive side.
Based on the Price/Earnings ratio, VMD is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of VMD to the average of the S&P500 Index (27.13), we can say VMD is valued slightly cheaper.
A Price/Forward Earnings ratio of 14.68 indicates a correct valuation of VMD.
76.47% of the companies in the same industry are more expensive than VMD, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of VMD to the average of the S&P500 Index (22.76), we can say VMD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.15 | ||
| Fwd PE | 14.68 |
4.2 Price Multiples
VMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VMD is cheaper than 90.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.32 |
4.3 Compensation for Growth
VMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VMD may justify a higher PE ratio.
VMD's earnings are expected to grow with 24.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)5.27
EPS Next 2Y32.27%
EPS Next 3Y24.89%
5. Dividend
5.1 Amount
No dividends for VMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:VMD (9/2/2025, 10:37:29 AM)
7.19
-0.18 (-2.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners65.63%
Inst Owner ChangeN/A
Ins Owners12.97%
Ins Owner Change0.17%
Market Cap278.90M
Analysts80
Price Target13.94 (93.88%)
Short Float %1.26%
Short Ratio1.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)1
Avg EPS beat(4)6.08%
Min EPS beat(4)-5.7%
Max EPS beat(4)32.01%
EPS beat(8)1
Avg EPS beat(8)-11.48%
EPS beat(12)3
Avg EPS beat(12)-7.67%
EPS beat(16)4
Avg EPS beat(16)-7.02%
Revenue beat(2)0
Avg Revenue beat(2)-2.23%
Min Revenue beat(2)-3.39%
Max Revenue beat(2)-1.06%
Revenue beat(4)2
Avg Revenue beat(4)-0.93%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)0.49%
Revenue beat(8)5
Avg Revenue beat(8)-0.39%
Revenue beat(12)8
Avg Revenue beat(12)0.05%
Revenue beat(16)12
Avg Revenue beat(16)0.96%
PT rev (1m)5.13%
PT rev (3m)6.49%
EPS NQ rev (1m)-5%
EPS NQ rev (3m)-13.64%
EPS NY rev (1m)-1.8%
EPS NY rev (3m)-1.8%
Revenue NQ rev (1m)4.14%
Revenue NQ rev (3m)4.61%
Revenue NY rev (1m)1.59%
Revenue NY rev (3m)1.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.15 | ||
| Fwd PE | 14.68 | ||
| P/S | 1.16 | ||
| P/FCF | N/A | ||
| P/OCF | 6.51 | ||
| P/B | 2 | ||
| P/tB | 2.63 | ||
| EV/EBITDA | 6.32 |
EPS(TTM)0.34
EY4.73%
EPS(NY)0.49
Fwd EY6.81%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)1.1
OCFY15.36%
SpS6.21
BVpS3.6
TBVpS2.73
PEG (NY)0.68
PEG (5Y)5.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.57% | ||
| ROE | 10% | ||
| ROCE | 11.16% | ||
| ROIC | 7.91% | ||
| ROICexc | 9.15% | ||
| ROICexgc | 12.45% | ||
| OM | 6.82% | ||
| PM (TTM) | 5.8% | ||
| GM | 58.33% | ||
| FCFM | N/A |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexcg growth 3Y2.65%
ROICexcg growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score8
Asset Turnover1.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.08 | ||
| Cap/Depr | 176.74% | ||
| Cap/Sales | 19.28% | ||
| Interest Coverage | 25.41 | ||
| Cash Conversion | 100.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 6.25 |
F-Score8
WACC8.93%
ROIC/WACC0.89
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)41.67%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%100%
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue 1Y (TTM)17.11%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%14.72%
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
EBIT growth 1Y5.79%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year209.91%
EBIT Next 3Y61.39%
EBIT Next 5YN/A
FCF growth 1Y-132.43%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y26.82%
OCF growth 3Y20.23%
OCF growth 5Y15.41%